Maternal control of germline development
Maternal control of germline development
批准号:
10155083
负责人:
Jing Yang
金额:
$38.31万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-07-01 至 2024-05-31
关键词:
AffectBindingCell ProliferationCellular biologyCodeCouplesDevelopmentDevelopmental BiologyEmbryoEnsureEnvironmentEventFertilizationGenetic TranscriptionGerm CellsGonadal structureHumanInfertilityKnowledgeLaboratory StudyLiteratureMessenger RNAModelingOocytesProliferatingRNARNA-Binding ProteinsReportingReproductive BiologyReproductive HealthResearchStructure of primordial sex cellSystemTimeTotipotencyTranslationsUbiquitinWorkXenopusegggonad developmentmulticatalytic endopeptidase complexnanonovelpreventrecruitsperm cellstem cell biology
中文摘要
摘要
原始生殖细胞(PGC)是配子的前体。PGC开发缺陷导致
生殖细胞减少或消除,并最终导致人类不育,影响10%-15%
情侣。在发育过程中,生殖细胞的出生比性腺的形成早得多。PGC必须
设法在非保护性的躯体环境中长期生存,然后迁徙很长时间
找到性腺的距离。PGC的规范和早期阶段的增殖是至关重要的
以确保足够数量的生殖细胞能够到达性腺并分化为配子。大号
大量文献表明,在迁移到性腺之前,PGC的发育严重依赖于
关于翻译和翻译后的监管机制。了解PGC的发展情况
因此,在翻译和翻译后层面上进行操作与人类生殖高度相关
健康。我的实验室使用非洲爪哇作为模型来研究早期PGC的发展。我们最近报道了
母体死亡末端1(DND1)在卵母细胞中的mRNA不对称定位中起重要作用。之后
受精,Dnd1招募翻译机器到Nanos mRNA并促进Nanos翻译。
通过这种机制,DND1阻止了原生殖细胞的体细胞分化,保护了它们的全能性。
我们最近的初步结果显示,DND1在卵母细胞中被泛素-1迅速降解。
独立的蛋白酶体系统。为了让DND1在之后积累和促进Nanos翻译
受精,编码蛋白酶体激活物的rna必须从dnd1和其他生殖系中分离出来。
卵母细胞向胚胎转变过程中的特定母体因素。我们打算研究这部小说是如何
MRNA易位事件为受精后PGC的启动发育做准备并进行调查
编码蛋白酶体激活子的RNA如何从dnd1和其他生殖系特异的母本中分离出来
卵母细胞向胚胎转化过程中的因素。此外,我们有一个令人兴奋的发现,第一个
PGC增殖波受母体Dzip1调控。我们将确定Dzip1是否监管PGC
通过结合和修饰生殖系特定的RNA结合蛋白的活性进行增殖。
此外,我们将确定作用于Dzip1下游的合子转录网络来控制
PGC增殖。这些工作将对我们理解基本细胞做出重要贡献,
生殖生物学和发育生物学。
英文摘要
Abstract
Primordial germ cells (PGCs) are the precursors of the gametes. Defective PGC development results in
reduction or elimination of germ cells and ultimately causes infertility in humans, which affects 10–15% of
couples. During development, PGCs are born much earlier than the formation of the gonads. PGCs must
manage to survive in the non-protective somatic environment for a long time and later migrate long
distances to find the gonads. Specification of PGCs and their proliferation during early stages are crucial
to ensure that sufficient number of PGCs can reach the gonads and differentiate into gametes. A large
body of literature has demonstrated that before migrating into the gonads, PGC development relies heavily
on translational and post-translational regulatory mechanisms. Understanding how PGC development is
operated at the translational and post-translation levels thus is highly relevant to human reproductive
health. My laboratory studies early PGC development using Xenopus as a model. We recently reported
that maternal Dead End1 (Dnd1) is important for asymmetric localization of mRNA in the oocyte. After
fertilization, Dnd1 recruits the translational machinery to nanos mRNA and promotes nanos translation.
Through this mechanism, Dnd1 prevents somatic differentiation of PGCs and protects their totipotency.
Our recent preliminary results reveal that Dnd1 is rapidly degraded in the oocyte by the ubiquitin-
independent proteasome system. In order for Dnd1 to accumulate and promote nanos translation after
fertilization, RNAs coding for proteasome activators must be separated from dnd1 and other germline
specific maternal factors during the oocyte-to-embryo transition. We propose to study how this novel
mRNA translocation event prepares for the initiation of PGC development after fertilization and investigate
how RNAs coding for proteasome activators are separated from dnd1 and other germline specific maternal
factors during the oocyte-to-embryo transition. Moreover, we have made an exciting finding that the first
wave of PGC proliferation is regulated by maternal Dzip1. We will determine if Dzip1 regulates PGC
proliferation via binding and modifying the activities of germline specific RNA-binding proteins.
Furthermore, we will identify the zygotic transcriptional network that acts downstream of Dzip1 to control
PGC proliferation. These works will make important contributions to our understanding of basic cell,
reproductive, and developmental biology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developing small molecule inhibitors of Pleckstrin-2 to treat thrombosis
-
批准号:10545992
-
项目类别:
-
资助金额:$39.72万
-
财政年份:2022
-
负责人:Jing Yang
-
依托单位:
Functional interplay between Hippo and estrogen receptor ESR1
-
批准号:10573162
-
项目类别:
-
资助金额:$42.57万
-
财政年份:2022
-
负责人:Jing Yang
-
依托单位:
Apical-basal polarity in tumor progression and metastasis
-
批准号:10468642
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2019
-
负责人:Jing Yang
-
依托单位:
Apical-basal polarity in tumor progression and metastasis
-
批准号:10228549
-
项目类别:
-
资助金额:$37.75万
-
财政年份:2019
-
负责人:Jing Yang
-
依托单位:
Maternal control of germline development
-
批准号:10410366
-
项目类别:
-
资助金额:$38.31万
-
财政年份:2019
-
负责人:Jing Yang
-
依托单位:
2019 International EMT Society meeting
-
批准号:9914655
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2019
-
负责人:Jing Yang
-
依托单位:
Apical-basal polarity in tumor progression and metastasis
-
批准号:10677660
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2019
-
负责人:Jing Yang
-
依托单位:
Maternal control of germline development
-
批准号:10625487
-
项目类别:
-
资助金额:$38.31万
-
财政年份:2019
-
负责人:Jing Yang
-
依托单位:
Role of integrin VLA-6 in suppression of bone formation in myeloma
-
批准号:9206148
-
项目类别:
-
资助金额:$37.02万
-
财政年份:2016
-
负责人:Jing Yang
-
依托单位:
Regulation of Tumor Invasion and Metastasis by Matrix Stiffness
-
批准号:10374409
-
项目类别:
-
资助金额:$36.38万
-
财政年份:2015
-
负责人:Jing Yang
-
依托单位:
Targeting adipocyte-secreted chemerin for chemotherapy resistance in myeloma
-
批准号:9105357
-
项目类别:
-
资助金额:$37.02万
-
财政年份:2015
-
负责人:Jing Yang
-
依托单位:
Regulation of Tumor Invasion and Metastasis by Matrix Stiffness
-
批准号:10557145
-
项目类别:
-
资助金额:$35.65万
-
财政年份:2015
-
负责人:Jing Yang
-
依托单位:
Regulation of Tumor Invasion and Metastasis by Matrix Stiffness
-
批准号:10738319
-
项目类别:
-
资助金额:$8.58万
-
财政年份:2015
-
负责人:Jing Yang
-
依托单位:
Regulation of Tumor Invasion and Metastasis by Matrix Stiffness
-
批准号:9315114
-
项目类别:
-
资助金额:$35.46万
-
财政年份:2015
-
负责人:Jing Yang
-
依托单位:
Targeting adipocyte-secreted chemerin for chemotherapy resistance in myeloma
-
批准号:8962918
-
项目类别:
-
资助金额:$37.02万
-
财政年份:2015
-
负责人:Jing Yang
-
依托单位:
Regulation of Tumor Invasion and Metastasis by Matrix Stiffness
-
批准号:8816864
-
项目类别:
-
资助金额:$35.46万
-
财政年份:2015
-
负责人:Jing Yang
-
依托单位:
Dnd1 and repression of transcription in primordial germ cells
-
批准号:8888237
-
项目类别:
-
资助金额:$30.53万
-
财政年份:2015
-
负责人:Jing Yang
-
依托单位:
Targeting adipocyte-secreted chemerin for chemotherapy resistance in myeloma
-
批准号:10128071
-
项目类别:
-
资助金额:$30.75万
-
财政年份:2015
-
负责人:Jing Yang
-
依托单位:
Regulation of Tumor Invasion and Metastasis by Matrix Stiffness
-
批准号:10599661
-
项目类别:
-
资助金额:$3.74万
-
财政年份:2015
-
负责人:Jing Yang
-
依托单位:
Dissecting molecular determinants of carcinoma dormancy in vivo
-
批准号:8976221
-
项目类别:
-
资助金额:$20.23万
-
财政年份:2014
-
负责人:Jing Yang
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: